Amjad Tonbari
Doha, DA, Qatar
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Use of subcutaneous epinephrine in addition to standard first-line treatment with short-acting β2-agonist and systemic steroids in children and adolescents with an acute severe asthma exacerbation: a systematic review of randomised controlled trials.
Journal: Archives of disease in childhood
Published: October 18, 2025
Use of inhaled/nebulised ipratropium bromide in addition to standard first-line treatment with inhaled/nebulised short-acting beta 2-agonist and systemic steroid in the management of acute asthma exacerbations: a systematic review and meta-analysis of randomised controlled trials.
Journal: Archives of disease in childhood
Published: August 23, 2024
Second-line treatment option for children aged 18 years and under with an acute severe asthma exacerbation: a systematic review and meta-analysis of randomised controlled trials.
Journal: Archives of disease in childhood
Published: August 11, 2024
Use of intravenous aminophylline in addition to the standard first-line treatment in children and adolescents with an acute asthma exacerbation: a systematic review and meta-analysis of randomised controlled trials.
Journal: Archives of disease in childhood
Published: June 04, 2024
Use of intravenous magnesium sulfate in addition to standard first-line treatment with inhaled/nebulised short-acting beta 2 agonist and systemic steroids in the management of acute asthma exacerbations in children: a systematic review and meta-analyses of randomised controlled trials.
Journal: Archives of disease in childhood
Published: June 02, 2024
Use of intravenous short-acting beta-2 agonist in addition to standard first-line treatment versus placebo in children and adolescents with acute severe asthma exacerbation: a systematic review and meta-analysis.
Journal: Archives of disease in childhood
Published: May 28, 2024
Reply to: Magnesium sulphate intravenously reduces tachycardia side-effects of β2-agonists.
Journal: Breathe (Sheffield, England)
Published: February 27, 2022
Stating the obvious: intravenous magnesium sulphate should be the first parenteral bronchodilator in paediatric asthma exacerbations unresponsive to first-line therapy.
Journal: Breathe (Sheffield, England)
Published: July 23, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026